Anika Therapeutics, Inc. (ANIK)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 381.83M |
| Enterprise Value | 341.68M |
| Trailing P/E | 43.00 |
| Forward P/E | 23.87 |
| PEG Ratio (5 yr expected) | 2.38 |
| Price/Sales (ttm) | 2.23 |
| Price/Book (mrq) | 1.83 |
| Enterprise Value/Revenue | 2.02 |
| Enterprise Value/EBITDA | -72.65 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.73 |
| 52-Week Change 3 | -4.70% |
| S&P500 52-Week Change 3 | 29.31% |
| 52 Week High 3 | 28.67 |
| 52 Week Low 3 | 16.54 |
| 50-Day Moving Average 3 | 25.84 |
| 200-Day Moving Average 3 | 22.29 |
Share Statistics
| Avg Vol (3 month) 3 | 78.66k |
| Avg Vol (10 day) 3 | 67.66k |
| Shares Outstanding 5 | 14.83M |
| Implied Shares Outstanding 6 | 14.83M |
| Float 8 | 10.93M |
| % Held by Insiders 1 | 2.97% |
| % Held by Institutions 1 | 91.40% |
| Shares Short (Apr 30, 2024) 4 | 808.11k |
| Short Ratio (Apr 30, 2024) 4 | 14.2 |
| Short % of Float (Apr 30, 2024) 4 | 7.53% |
| Short % of Shares Outstanding (Apr 30, 2024) 4 | 5.45% |
| Shares Short (prior month Mar 28, 2024) 4 | 770.4k |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Mar 31, 2024 |
Profitability
| Profit Margin | -45.39% |
| Operating Margin (ttm) | -23.67% |
Management Effectiveness
| Return on Assets (ttm) | -1.81% |
| Return on Equity (ttm) | -31.61% |
Income Statement
| Revenue (ttm) | 169.26M |
| Revenue Per Share (ttm) | 11.54 |
| Quarterly Revenue Growth (yoy) | 6.90% |
| Gross Profit (ttm) | N/A |
| EBITDA | 3.99M |
| Net Income Avi to Common (ttm) | -76.83M |
| Diluted EPS (ttm) | -5.24 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 68.63M |
| Total Cash Per Share (mrq) | 4.63 |
| Total Debt (mrq) | 28.47M |
| Total Debt/Equity (mrq) | 13.65% |
| Current Ratio (mrq) | 5.59 |
| Book Value Per Share (mrq) | 14.07 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 1.7M |
| Levered Free Cash Flow (ttm) | 6.54M |
© 2024 Yahoo. All rights reserved.